Biblio
Export 172 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is X [Clear All Filters]
“Impaired Center-Surround Suppression in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1101-1108, 2017.
, “Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 509-520, 2017.
, “Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 509-520, 2017.
, “Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process.”, J Alzheimers Dis, vol. 56, no. 2, pp. 491-507, 2017.
, “Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1109-1121, 2017.
, “Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1403-1417, 2017.
, “Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 60, no. 2, pp. 461-481, 2017.
, “Pen-2 and Presenilin are Sufficient to Catalyze Notch Processing.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1263-1269, 2017.
, “Pen-2 and Presenilin are Sufficient to Catalyze Notch Processing.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1263-1269, 2017.
, “Prevalence, Risk Factors, and Complaints Screening Tool Exploration of Subjective Cognitive Decline in a Large Cohort of the Chinese Population.”, J Alzheimers Dis, vol. 60, no. 2, pp. 371-388, 2017.
, “proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice.”, J Alzheimers Dis, vol. 59, no. 3, pp. 941-949, 2017.
, “PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β.”, J Alzheimers Dis, vol. 59, no. 3, pp. 913-927, 2017.
, “Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.”, J Alzheimers Dis, vol. 59, no. 2, pp. 527-536, 2017.
, “Rapidly Progressive Frontotemporal Dementia Associated with MAPT Mutation G389R.”, J Alzheimers Dis, vol. 55, no. 2, pp. 777-785, 2017.
, “SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 835-847, 2017.
, “SORL1 Variants Show Different Association with Early-Onset and Late-Onset Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1121-1128, 2017.
, “Tai Chi Chuan and Baduanjin Increase Grey Matter Volume in Older Adults: A Brain Imaging Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 389-400, 2017.
, “Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1083-1099, 2017.
, “TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1027-1033, 2017.
, “Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 1, pp. 87-95, 2017.
, “Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1223-1227, 2017.
, “Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and concomitant Lacunar Infarction: A Resting-State Functional MRI Study.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1243-54, 2016.
, “Age-Related Changes in the Synaptic Density of Amyloid-β Protein Precursor and Secretases in the Human Cerebral Cortex.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1209-14, 2016.
, “Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid.”, J Alzheimers Dis, vol. 49, no. 3, pp. 829-44, 2016.
, “Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 529-38, 2016.
,